PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25986738-7	2015	Importantly, pharmacological inhibition of sEH with 12-(3-adamantan-1-yl- ureido)-dodecanoic acid (AUDA) markedly suppressed PI3K-Akt activation and GSK-3beta phosphorylation.	12-(3-adamantan-1-ylureido)dodecanoic acid	52-97	AKT serine/threonine kinase 1	Rattus norvegicus	130-133	
25986738-7	2015	Importantly, pharmacological inhibition of sEH with 12-(3-adamantan-1-yl- ureido)-dodecanoic acid (AUDA) markedly suppressed PI3K-Akt activation and GSK-3beta phosphorylation.	12-(3-adamantan-1-ylureido)dodecanoic acid	99-103	AKT serine/threonine kinase 1	Rattus norvegicus	130-133	
25986738-9	2015	Furthermore, in rats with chronic proteinuric renal disease, AUDA treatment inhibited PI3K-Akt activation and GSK-3beta phosphorylation, while attenuating levels of EMT markers.	12-(3-adamantan-1-ylureido)dodecanoic acid	61-65	AKT serine/threonine kinase 1	Rattus norvegicus	91-94